Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study.
Goktas Aydin S, Kavak EE, Topcu A, Bayramgil A, Akgul F, Kahraman S, Aykan MB, Altıntas YE, Helvaci K, Urun Y, Bilici A, Seker M, Sendur MAN, Olmez OF, Acikgoz O, Cicin I.
Goktas Aydin S, et al. Among authors: kavak ee.
Biomol Biomed. 2023 Nov 3;23(6):1089-1095. doi: 10.17305/bb.2023.9253.
Biomol Biomed. 2023.
PMID: 37289436
Free PMC article.